APOD and diabetic kidney disease: In addition, although there is no direct evidence of a cause-effect relationship, the findings point to apoD and apoA-IV as markers of DKD that may contribute to HDL function, despite lipoprotein chemical modification by carbamoylation and advanced glycation, which deserves future investigation.